Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

22. Juli 2015 07:00 ET | Quelle: Lumos Pharma, Inc.

NewLink Genetics Announces That Dr. Thomas Monath Received Award From American Veterinary Epidemiology Society for Contributions to Public Health

AMES, Iowa, July 22, 2015 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (Nasdaq:NLNK), a biopharmaceutical company at the forefront of developing novel immuno-oncology and infectious-disease...
14. Juli 2015 16:00 ET | Quelle: Lumos Pharma, Inc.

NewLink Genetics Shares Immuno-Oncology Vision at Investor Day

AMES, Iowa, July 14, 2015 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (Nasdaq:NLNK), a biopharmaceutical company at the forefront of developing and commercializing novel immuno-oncology...
08. Juli 2015 16:00 ET | Quelle: Lumos Pharma, Inc.

NewLink Genetics to Webcast 2015 Investor Day on July 14, 2015

AMES, Iowa, July 08, 2015 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced that it will provide a company update at its 2015 Investor Day on Tuesday, July 14...
06. Juli 2015 07:00 ET | Quelle: Lumos Pharma, Inc.

NewLink Genetics to Present at the Cantor Fitzgerald Healthcare Conference

AMES, Iowa, July 06, 2015 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (NASDAQ:NLNK) today announced that it will present at the Cantor Fitzgerald Healthcare Conference on Wednesday, July 8,...
29. Mai 2015 08:22 ET | Quelle: Lumos Pharma, Inc.

NewLink Genetics to Present at the Jefferies Global Healthcare Conference

AMES, Iowa, May 29, 2015 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (Nasdaq:NLNK) today announced that it will present at the Jefferies Global Healthcare Conference on Wednesday, June 3, 2015 at...
26. Mai 2015 12:05 ET | Quelle: Lumos Pharma, Inc.

NewLink Genetics to Present Poster on Indoximod, an IDO Pathway Inhibitor, at American Society of Clinical Oncology (ASCO) Annual Meeting

AMES, Iowa, May 26, 2015 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (Nasdaq:NLNK), a biopharmaceutical company focused on bringing novel immuno-oncology medicines to patients with cancer, today...
11. Mai 2015 16:05 ET | Quelle: Lumos Pharma, Inc.

NewLink Genetics' IMPRESS Phase 3 Pancreatic Cancer Trial with Algenpantucel-L to Continue Following Second Interim Analysis

AMES, Iowa, May 11, 2015 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (Nasdaq:NLNK), a biopharmaceutical company focused on bringing novel immuno-oncology medicines to patients with cancer, today...
05. Mai 2015 07:00 ET | Quelle: Lumos Pharma, Inc.

NewLink Genetics Corporation Provides Operational Update and Reports First Quarter 2015 Financial Results

AMES, Iowa, May 5, 2015 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (Nasdaq:NLNK), a biopharmaceutical company focused on bringing novel immuno-oncology medicines to patients with cancer, today...
29. April 2015 07:00 ET | Quelle: Lumos Pharma, Inc.

NewLink Genetics to Participate in Two Upcoming Investor Conferences

AMES, Iowa, April 29, 2015 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (Nasdaq:NLNK) today announced that it will participate in two upcoming investor conferences: On Wednesday, May 6, 2015,...
24. April 2015 07:00 ET | Quelle: Lumos Pharma, Inc.

NewLink Genetics Supports the Fight Against Pancreatic Cancer at PurpleStride 2015 Events in Austin, Los Angeles and Des Moines

AMES, Iowa, April 24, 2015 (GLOBE NEWSWIRE) -- NewLink Genetics Corporation (Nasdaq:NLNK), a biopharmaceutical company focused on bringing novel immuno-oncology medicines to patients with cancer...

Vorherige Seite

Nächste Seite